Press release
Metastatic Castration-Resistant Prostate Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Surface Oncology, Regeneron Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer Pipeline Insights
Metastatic Castration-Resistant Prostate Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma, Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen
Metastatic Castration-Resistant Prostate Cancer Pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Castration-Resistant Prostate Cancer treatment therapies, analyzes DelveInsight.
Metastatic Castration-Resistant Prostate Cancer Overview:
Prostate cancer (PCa) is one of the most commonly diagnosed cancers globally and stands as the third leading cause of cancer-related deaths among men in the United States. In most cases, the disease is initially found in a localized stage and is treated with radical prostatectomy and/or radiation therapy, often followed by androgen deprivation therapy (ADT). However, depending on the tumor's aggressiveness, some patients may develop castration-resistant prostate cancer (CRPC) within ten years. Formerly referred to as "hormone-refractory" or "androgen-independent" prostate cancer, CRPC continues to depend on androgen receptor (AR) signaling despite becoming unresponsive to standard hormone-suppressing treatments like ADT.
Request for a detailed insights report on Metastatic Castration-Resistant Prostate Cancer pipeline insights [https://www.delveinsight.com/report-store/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Metastatic Castration-Resistant Prostate Cancer Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Metastatic Castration-Resistant Prostate Cancer Therapeutics Market.
Key Takeaways from the Metastatic Castration-Resistant Prostate Cancer Pipeline Report
*
DelveInsight's Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic Castration-Resistant Prostate Cancer treatment.
*
In September 2024, Ipsen announced that the Phase III CONTACT-02 trial for Cabometyx Registered and atezolizumab in metastatic castration-resistant prostate cancer (mCRPC) showed a non-significant improvement in overall survival but successfully met the progression-free survival (PFS) endpoint.
*
Also in September 2024, Foundation Medicine received FDA approval for FoundationOne Registered CDx and Liquid CDx as companion diagnostics for Lynparza Registered in BRCA-mutated mCRPC.
*
In July 2024, the ARANOTE trial demonstrated that NUBEQA Registered plus ADT significantly improved radiological PFS in metastatic hormone-sensitive castrate-resistant prostate cancer (mHSPC).
*
In July 2024, the FDA granted fast-track designation to SYNC-T SV-102 for mCRPC.
*
In June 2024, Kangpu Biopharmaceuticals received FDA approval for a Phase II/III trial of KPG-121 combined with Abiraterone for mCRPC.
*
In May 2024, Fusion Pharmaceuticals launched the Phase 2 AlphaBreak trial of FPI-2265 in mCRPC patients.
*
In April 2024, Astellas Pharma obtained European approval for XTANDI Trademark in high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer (nmHSPC).
*
In April 2024, FibroGen reported positive Phase 1 trial results for FG-3246 in mCRPC.
*
Key Metastatic Castration-Resistant Prostate Cancer companies such as Surface Oncology, Regeneron Pharmaceuticals, Clovis Oncology, AstraZeneca, Veru Healthcare, Hinova Pharmaceuticals, Zenith Epigenetic, Eli Lilly and Company, Lantern Pharma, Astellas Pharma, Seagen, Pfizer, Progenics Pharmaceutical, Molecular Insight Pharmaceuticals, Bayer, Accutar Biotechnology Inc, Hinova Pharmaceuticals, Taiho Oncology, Inc., Forma Therapeutics, Inc., Dizal Pharmaceuticals, Amgen, and others are evaluating new drugs for Metastatic Castration-Resistant Prostate Cancer to improve the treatment landscape.
*
Promising Metastatic Castration-Resistant Prostate Cancer pipeline therapies in various stages of development include SRF617, Rucaparib, HP518, and others.
Metastatic Castration-Resistant Prostate Cancer Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Metastatic Castration-Resistant Prostate Cancer Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Castration-Resistant Prostate Cancer treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Metastatic Castration-Resistant Prostate Cancer market.
Download our free sample page report on Metastatic Castration-Resistant Prostate Cancer pipeline insights [https://www.delveinsight.com/sample-request/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Metastatic Castration-Resistant Prostate Cancer Emerging Drugs
*
SRF617: Surface Oncology
*
Rucaparib: Clovis Oncology
*
HP518: Hinova Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer Companies
Over 75 leading companies are actively engaged in developing therapies for metastatic castration-resistant prostate cancer (mCRPC). Clovis Oncology is among those with a drug candidate in the most advanced stage of development, currently in Phase III clinical trials.
DelveInsight's report covers around 75+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Metastatic Castration-Resistant Prostate Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Metastatic Castration-Resistant Prostate Cancer Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Metastatic Castration-Resistant Prostate Cancer Therapies and Key Companies: Metastatic Castration-Resistant Prostate Cancer Clinical Trials and advancements [https://www.delveinsight.com/report-store/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Metastatic Castration-Resistant Prostate Cancer Pipeline Therapeutic Assessment
- Metastatic Castration-Resistant Prostate Cancer Assessment by Product Type
- Metastatic Castration-Resistant Prostate Cancer By Stage
- Metastatic Castration-Resistant Prostate Cancer Assessment by Route of Administration
- Metastatic Castration-Resistant Prostate Cancer Assessment by Molecule Type
Download Metastatic Castration-Resistant Prostate Cancer Sample report to know in detail about the Metastatic Castration-Resistant Prostate Cancer treatment market @ Metastatic Castration-Resistant Prostate Cancer Therapeutic Assessment [https://www.delveinsight.com/sample-request/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Metastatic Castration-Resistant Prostate Cancer Current Treatment Patterns
4. Metastatic Castration-Resistant Prostate Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Metastatic Castration-Resistant Prostate Cancer Late-Stage Products (Phase-III)
7. Metastatic Castration-Resistant Prostate Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Metastatic Castration-Resistant Prostate Cancer Discontinued Products
13. Metastatic Castration-Resistant Prostate Cancer Product Profiles
14. Metastatic Castration-Resistant Prostate Cancer Key Companies
15. Metastatic Castration-Resistant Prostate Cancer Key Products
16. Dormant and Discontinued Products
17. Metastatic Castration-Resistant Prostate Cancer Unmet Needs
18. Metastatic Castration-Resistant Prostate Cancer Future Perspectives
19. Metastatic Castration-Resistant Prostate Cancer Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Metastatic Castration-Resistant Prostate Cancer Pipeline Reports Offerings [https://www.delveinsight.com/report-store/metastatic-castration-resistant-prostate-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=metastatic-castrationresistant-prostate-cancer-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-analysis-surface-oncology-regeneron-pharmaceuticals]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Castration-Resistant Prostate Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Surface Oncology, Regeneron Pharmaceuticals here
News-ID: 4115029 • Views: …
More Releases from ABNewswire
Denver's Best Appliance Repair Responds to Rising Demand for Emergency Appliance …
Denver's Best Appliance Repair expands emergency services across the Denver metro with same-day repairs, 7-day availability, 5-year parts warranty, and professional licensed technicians serving residential and commercial clients.
Household appliance failures don't follow a schedule. When a refrigerator stops cooling in the middle of summer or a washing machine floods a basement on a Sunday evening, families need immediate help. Denver's Best Appliance Repair has responded to this growing need by…
Oak Hill Clinic Reaches 30,000 Client Milestone with Results-Driven Deep Tissue …
Deep Relief in Oak Hill, Austin, has served 30,000 clients through specialized massage, chiropractic, and acupuncture care. The clinic accepts insurance and focuses on results-driven treatments for pain relief.
Deep Relief, an Oak Hill-based wellness clinic, has achieved a significant milestone by serving more than 30,000 clients seeking Relief from chronic pain, muscle tension, and mobility issues. The clinic's success stems from its commitment to advanced, results-focused bodywork that goes beyond…
Vertex Fleet Expands Nationwide Network to Combat Growing Trailer Drop Yard Shor …
Vertex Fleet announces major expansion of secure parking facilities nationwide, addressing the critical shortage of commercial vehicle storage with 15+ new locations featuring 24/7 security and technology-driven access.
The freight and logistics industry faces a mounting crisis as demand for secure parking spaces continues to outpace supply across the United States. Vertex Fleet [https://www.vertexfleet.com/], a leading provider of industrial outdoor storage solutions, has announced significant expansion plans to address this critical…
HVAC in Denver Sees Service Enhancement as Denver's Best Heating and AC Repair L …
Denver's Best Heating and AC Repair expands 24/7 emergency services across 23 metro cities, offering A+ rated heating, cooling, and commercial HVAC solutions with rapid response times and multi-brand expertise.
Denver's Best Heating and AC Repair [https://www.denversbestheatingandacrepair.com/]has expanded its service capabilities to meet growing demand for reliable heating and cooling solutions across the Denver Metro area. The A+ rated contractor now provides 24/7 emergency response services to 23 cities, addressing critical…
More Releases for Prostate
The 3D Urology and Prostate Clinics Introduces Innovative Natural and Targeted P …
The 3D Urology and Prostate Clinics introduces its innovative 3D targeted injection therapies, offering effective, natural solutions for various prostate conditions including prostatitis, enlarged prostate, and prostate cancer.
Renowned for its pioneering approach to prostate health, The 3D Urology and Prostate Clinics is bringing renewed hope to patients worldwide suffering from various prostate diseases. Utilizing advanced diagnostic techniques and a unique targeted injection method, the clinics offer specialized treatments that focus…
The 3D Urology and Prostate Clinics Introduces Advanced 3D Prostate Targeted Tre …
The 3D Urology and Prostate Clinics announces its latest breakthrough in targeted prostate treatment, offering a revolutionary approach to prostate cancer and other prostate-related conditions.
The 3D Urology and Prostate Clinics, renowned for its advanced techniques in prostate health, is proud to present its groundbreaking 3D prostate Targeted Treatment, a comprehensive and non-invasive solution for men suffering from prostate conditions. The clinic's innovative treatment is designed to target the root causes…
The 3D Urology and Prostate Clinics Unveil Innovative 3D Prostate Targeted Treat …
The 3D Urology and Prostate Clinics introduce their groundbreaking 3D prostate targeted treatment, offering a non-invasive solution for prostate health issues.
The 3D Urology and Prostate Clinics, renowned for their specialized treatments in prostate health, are proud to unveil their innovative 3D prostate targeted treatment. This cutting-edge therapy provides a non-invasive, highly effective solution for prostate-related conditions, offering patients a new path to recovery and well-being.Image: https://i.imgur.com/NCfbb6S.jpg
At the heart of this…
The 3D Urology and Prostate Clinics Unveils Advanced 3D prostate Targeted Treatm …
The 3D Urology and Prostate Clinics is at the forefront of prostate care, offering the advanced 3D Targeted Therapy as a precise and effective treatment solution.
The 3D Urology and Prostate Clinics is proud to announce its revolutionary 3D prostate Targeted Treatment [http://www.3dprostatecure.com/page.php?cata_id=19], setting a new standard in prostate care. This highly advanced treatment option utilizes cutting-edge technology to deliver focused treatment, minimizing side effects and enhancing recovery for patients. Men…
3D Prostate Cure: Revolutionizing Prostate Treatment with Targeted Therapy
This news release highlights the 3D Urology and Prostate Clinics' innovative approach to prostate treatment using 3D Targeted Therapy, offering a safe and effective alternative to traditional methods.
As a global leader in men's health, The 3D Urology and Prostate Clinics is committed to providing cutting-edge treatments for various prostate conditions. The clinic is proud to announce its revolutionary 3D Targeted Therapy, offering a new standard in prostate care.
This innovative therapy…
The 3D Urology and Prostate Clinics Enhance Prostate Health with Advanced 3D Pro …
The 3D Urology and Prostate Clinics are revolutionizing prostate care with their comprehensive treatments, including the 3D prostate Targeted Treatment and 3D Targeted Therapy, developed to ensure effective, non-surgical solutions for prostate health issues.
At the forefront of prostate health, The 3D Urology and Prostate Clinics are excited to offer innovative treatments such as the 3D prostate Targeted Treatment and 3D Targeted Therapy. These treatments are part of the clinic's commitment…
